AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-85
Results: 26-50/85
HYPERHOMOCYSTEINEMIA - A RISK FACTOR FOR PRIMARY DEEP-VEIN THROMBOSIS
Authors: DENHEIJER M KOSTER T BLOM HJ BOS GMJ BRIET E VANDENBROUCKE JP ROSENDAAL FR
Citation: M. Denheijer et al., HYPERHOMOCYSTEINEMIA - A RISK FACTOR FOR PRIMARY DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1110-1110
THE OPTIMAL INTENSITY OF ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES
Authors: CANNEGIETER SC ROSENDAAL FR WINTZEN AR VANDERMEER FJM VANDENBROUCKE JP BRIET E
Citation: Sc. Cannegieter et al., THE OPTIMAL INTENSITY OF ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES, Thrombosis and haemostasis, 73(6), 1995, pp. 1116-1116
GENETIC-CHARACTERIZATION OF TYPE-3 AND TYPE-1 VON-WILLEBRAND DISEASE (VWD) PATIENTS IN THE VENETO REGION - FOUNDER EFFECT AND RELATIONSHIP WITH DESMOPRESSIN RESPONSIVENESS
Authors: CASTAMAN G EIKENBOOM JCJ REITSMA PH RODEGHIERO F BRIET E
Citation: G. Castaman et al., GENETIC-CHARACTERIZATION OF TYPE-3 AND TYPE-1 VON-WILLEBRAND DISEASE (VWD) PATIENTS IN THE VENETO REGION - FOUNDER EFFECT AND RELATIONSHIP WITH DESMOPRESSIN RESPONSIVENESS, Thrombosis and haemostasis, 73(6), 1995, pp. 1170-1170
DOMINANT TYPE-1 VON-WILLEBRAND DISEASE-ASSOCIATED WITH MUTATED CYSTEINE RESIDUES IN THE D3-DOMAIN OF VON-WILLEBRAND-FACTOR
Authors: EIKENBOOM JCJ REITSMA PH CASTAMAN G TULEY EA BRIET E SADLER JE
Citation: Jcj. Eikenboom et al., DOMINANT TYPE-1 VON-WILLEBRAND DISEASE-ASSOCIATED WITH MUTATED CYSTEINE RESIDUES IN THE D3-DOMAIN OF VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 73(6), 1995, pp. 1170-1170
FACTOR-VIII ANTIGEN IN A PATIENT AFFECTED BY SEVERE HEMOPHILIA-A WHO HAS THE INVERSION IN THE FACTOR-VIII GENE
Authors: PIENEMAN WC VANTILBURG NH REITSMA PH BRIET E
Citation: Wc. Pieneman et al., FACTOR-VIII ANTIGEN IN A PATIENT AFFECTED BY SEVERE HEMOPHILIA-A WHO HAS THE INVERSION IN THE FACTOR-VIII GENE, Thrombosis and haemostasis, 73(6), 1995, pp. 1223-1223
NO EXCESS MORTALITY IN HETEROZYGOTES FOR HEREDITARY PROTEIN-C DEFICIENCY TYPE-I - 1820 TO 1993
Authors: ALLAART CF ROSENDAAL FR NOTEBOOM WMP BRIET E
Citation: Cf. Allaart et al., NO EXCESS MORTALITY IN HETEROZYGOTES FOR HEREDITARY PROTEIN-C DEFICIENCY TYPE-I - 1820 TO 1993, Thrombosis and haemostasis, 73(6), 1995, pp. 1252-1252
RISK-FACTORS FOR THROMBOEMBOLISM AND BLEEDING IN THE ANTICOAGULANT TREATMENT OF PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES
Authors: CANNEGIETER SC ROSENDAAL FR WINTZEN AR VANDENBROUCKE JP BRIET E
Citation: Sc. Cannegieter et al., RISK-FACTORS FOR THROMBOEMBOLISM AND BLEEDING IN THE ANTICOAGULANT TREATMENT OF PATIENTS WITH MECHANICAL HEART-VALVE PROSTHESES, Thrombosis and haemostasis, 73(6), 1995, pp. 1402-1402
ROLE OF CLOTTING FACTOR-VIII IN EFFECT OF VON-WILLEBRAND-FACTOR ON OCCURRENCE OF DEEP-VEIN THROMBOSIS
Authors: KOSTER T BLANN AD BRIET E VANDENBROUCKE JP ROSENDAAL FR
Citation: T. Koster et al., ROLE OF CLOTTING FACTOR-VIII IN EFFECT OF VON-WILLEBRAND-FACTOR ON OCCURRENCE OF DEEP-VEIN THROMBOSIS, Lancet, 345(8943), 1995, pp. 152-155
OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES
Authors: CANNEGIETER SC ROSENDAAL FR WINTZEN AR VANDERMEER FJM VANDENBROUCKE JP BRIET E
Citation: Sc. Cannegieter et al., OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES, The New England journal of medicine, 333(1), 1995, pp. 11-17
INVERSIONS IN THE FACTOR-VIII GENE - IMPROVEMENT OF CARRIER DETECTIONAND PRENATAL-DIAGNOSIS IN DUTCH HEMOPHILIA-A FAMILIES
Authors: DEUTZTERLOUW PP LOSEKOOT M OLMER R PIENEMAN WC DEVRIESVANDERWEERD S BRIET E BAKKER E
Citation: Pp. Deutzterlouw et al., INVERSIONS IN THE FACTOR-VIII GENE - IMPROVEMENT OF CARRIER DETECTIONAND PRENATAL-DIAGNOSIS IN DUTCH HEMOPHILIA-A FAMILIES, Journal of Medical Genetics, 32(4), 1995, pp. 296-300
SCREENING FOR MUTATIONS IN HEMOPHILIA-A PATIENTS BY MULTIPLEX PCR-SSCP, SOUTHERN BLOTTING AND RNA ANALYSIS - THE DETECTION OF A GENETIC ABNORMALITY IN THE FACTOR-VIII GENE IN 30 OUT OF 35 PATIENTS
Authors: PIENEMAN WC DEUTZTERLOUW PP REITSMA PH BRIET E
Citation: Wc. Pieneman et al., SCREENING FOR MUTATIONS IN HEMOPHILIA-A PATIENTS BY MULTIPLEX PCR-SSCP, SOUTHERN BLOTTING AND RNA ANALYSIS - THE DETECTION OF A GENETIC ABNORMALITY IN THE FACTOR-VIII GENE IN 30 OUT OF 35 PATIENTS, British Journal of Haematology, 90(2), 1995, pp. 442-449
A NOVEL CANDIDATE MUTATION (ARG(6LL)-]HIS) IN TYPE-I PLATELET DISCORDANT VON WILLEBRANDS DISEASE WITH DESMOPRESSIN-INDUCED THROMBOCYTOPENIA
Authors: CASTAMAN G EIKENBOOM JCJ RODEGHIERO F BRIET E REITSMA PH
Citation: G. Castaman et al., A NOVEL CANDIDATE MUTATION (ARG(6LL)-]HIS) IN TYPE-I PLATELET DISCORDANT VON WILLEBRANDS DISEASE WITH DESMOPRESSIN-INDUCED THROMBOCYTOPENIA, British Journal of Haematology, 89(3), 1995, pp. 656-658
FAMILY HISTORY AND INHERITED THROMBOPHILIA
Authors: BRIET E VANDERMEER FJ ROSENDAAL FR HOUWINGDUISTERMAAT JJ VANHOUWELINGEN HC
Citation: E. Briet et al., FAMILY HISTORY AND INHERITED THROMBOPHILIA, British Journal of Haematology, 89(3), 1995, pp. 691-691
11 NOVEL MUTATIONS IN THE FACTOR-VIII GENE FROM BRAZILIAN HEMOPHILIA-A PATIENTS
Authors: ARRUDA VR PIENEMAN WC REITSMA PH DEUTZTERLOUW PP ANNICHINOBIZZACCHI JM BRIET E COSTA FF
Citation: Vr. Arruda et al., 11 NOVEL MUTATIONS IN THE FACTOR-VIII GENE FROM BRAZILIAN HEMOPHILIA-A PATIENTS, Blood, 86(8), 1995, pp. 3015-3020
EXPRESSION OF THE BLOOD-CLOTTING FACTOR-VIII CDNA IS REPRESSED BY A TRANSCRIPTIONAL SILENCER LOCATED IN ITS CODING REGION
Authors: HOEBEN RC FALLAUX FJ CRAMER SJ VANDENWOLLENBERG DJM VANORMONDT H BRIET E VANDEREB AJ
Citation: Rc. Hoeben et al., EXPRESSION OF THE BLOOD-CLOTTING FACTOR-VIII CDNA IS REPRESSED BY A TRANSCRIPTIONAL SILENCER LOCATED IN ITS CODING REGION, Blood, 85(9), 1995, pp. 2447-2454
PROTEIN-C DEFICIENCY IN A CONTROLLED SERIES OF UNSELECTED OUTPATIENTS- AN INFREQUENT BUT CLEAR RISK FACTOR FOR VENOUS THROMBOSIS (LEIDEN THROMBOPHILIA STUDY)
Authors: KOSTER T ROSENDAAL FR BRIET E VANDERMEER FJM COLLY LP TRIENEKENS PH POORT SR REITSMA PH VANDENBROUCKE JP
Citation: T. Koster et al., PROTEIN-C DEFICIENCY IN A CONTROLLED SERIES OF UNSELECTED OUTPATIENTS- AN INFREQUENT BUT CLEAR RISK FACTOR FOR VENOUS THROMBOSIS (LEIDEN THROMBOPHILIA STUDY), Blood, 85(10), 1995, pp. 2756-2761
USEFULNESS OF PATIENT INTERVIEW IN BLEEDING DISORDERS
Authors: SRAMEK A EIKENBOOM JCJ BRIET E VANDENBROUCHE JP ROSENDAAL FR
Citation: A. Sramek et al., USEFULNESS OF PATIENT INTERVIEW IN BLEEDING DISORDERS, Archives of internal medicine, 155(13), 1995, pp. 1409-1415
MORTALITY IN PATIENTS WITH HEMOPHILIA - CHANGES IN A DUTCH POPULATIONFROM 1986 TO 1992 AND 1973 TO 1986
Authors: TRIEMSTRA M ROSENDAAL FR SMIT C VANDERPLOEG HM BRIET E
Citation: M. Triemstra et al., MORTALITY IN PATIENTS WITH HEMOPHILIA - CHANGES IN A DUTCH POPULATIONFROM 1986 TO 1992 AND 1973 TO 1986, Annals of internal medicine, 123(11), 1995, pp. 823
REPORT OF A JOINT WHO WFH MEETING ON THE CONTROL OF HEMOPHILIA - CARRIER DETECTION AND PRENATAL-DIAGNOSIS (VOL 4, PG 313, 1993)/
Authors: PEAKE IR LILLICRAP DP BOULYJENKOV V BRIET E CHAN V GINTER EK KRAUS EM LJUNG R
Citation: Ir. Peake et al., REPORT OF A JOINT WHO WFH MEETING ON THE CONTROL OF HEMOPHILIA - CARRIER DETECTION AND PRENATAL-DIAGNOSIS (VOL 4, PG 313, 1993)/, Blood coagulation & fibrinolysis, 5(1), 1994, pp. 148-148
DIURNAL CHANGES IN HEPARIN EFFECT DURING CONTINUOUS CONSTANT-RATE INFUSION - A STUDY IN 9 PATIENTS WITH VENOUS THROMBOEMBOLISM
Authors: KRULDER JWM VANDENBESSELAAR AMHP VANDERMEER FJM MEINDERS AE BRIET E
Citation: Jwm. Krulder et al., DIURNAL CHANGES IN HEPARIN EFFECT DURING CONTINUOUS CONSTANT-RATE INFUSION - A STUDY IN 9 PATIENTS WITH VENOUS THROMBOEMBOLISM, Journal of internal medicine, 235(5), 1994, pp. 411-417
SEEMING HOMOZYGOSITY IN TYPE-IIB VON WILLEBRANDS DISEASE DUE TO A POLYMORPHISM WITHIN THE SEQUENCE OF A COMMONLY USED PRIMER
Authors: EIKENBOOM JCJ REITSMA PH BRIET E
Citation: Jcj. Eikenboom et al., SEEMING HOMOZYGOSITY IN TYPE-IIB VON WILLEBRANDS DISEASE DUE TO A POLYMORPHISM WITHIN THE SEQUENCE OF A COMMONLY USED PRIMER, Annals of hematology, 68(3), 1994, pp. 139-141
OPTIMAL INTENSITY OF ORAL ANTICOAGULANT-THERAPY IN 3404 POSTMYOCARDIAL INFARCTION PATIENTS
Authors: AZAR AJ DECKERS JW ROSENDAAL FR BRIET E
Citation: Aj. Azar et al., OPTIMAL INTENSITY OF ORAL ANTICOAGULANT-THERAPY IN 3404 POSTMYOCARDIAL INFARCTION PATIENTS, Journal of the American College of Cardiology, 1994, pp. 10000412-10000412
ASSESSMENT OF THERAPEUTIC QUALITY-CONTROL IN A LONG-TERM ANTICOAGULANT TRIAL IN POSTMYOCARDIAL INFARCTION PATIENTS
Authors: AZAR AJ DECKERS JW ROSENDAAL FR VANBERGEN PFMM VANDERMEER FJM JONKER JJC BRIET E
Citation: Aj. Azar et al., ASSESSMENT OF THERAPEUTIC QUALITY-CONTROL IN A LONG-TERM ANTICOAGULANT TRIAL IN POSTMYOCARDIAL INFARCTION PATIENTS, Thrombosis and haemostasis, 72(3), 1994, pp. 347-351
HIGH-TITER INHIBITORS IN SEVERE HEMOPHILIA-A - A METAANALYSIS BASED ON 8 LONG-TERM FOLLOW-UP-STUDIES CONCERNING INHIBITORS ASSOCIATED WITH CRUDE OR INTERMEDIATE PURITY FACTOR-VIII PRODUCTS
Authors: BRIET E ROSENDAAL FR KREUZ W RASI V PEERLINCK K VERMYLEN J LJUNG R ROCINO A ADDIEGO J LORENZO JI PABINGER I
Citation: E. Briet et al., HIGH-TITER INHIBITORS IN SEVERE HEMOPHILIA-A - A METAANALYSIS BASED ON 8 LONG-TERM FOLLOW-UP-STUDIES CONCERNING INHIBITORS ASSOCIATED WITH CRUDE OR INTERMEDIATE PURITY FACTOR-VIII PRODUCTS, Thrombosis and haemostasis, 72(1), 1994, pp. 162-164
CLINICAL COURSE OF FACTOR-VIII INHIBITORS DEVELOPED AFTER EXPOSURE TOA PASTEURIZED DUTCH CONCENTRATE COMPARED TO CLASSIC INHIBITORS IN HEMOPHILIA-A
Authors: MAUSERBUNSCHOTEN EP ROSENDAAL FR NIEUWENHUIS HK ROOSENDAAL G BRIET E VANDENBERG HM
Citation: Ep. Mauserbunschoten et al., CLINICAL COURSE OF FACTOR-VIII INHIBITORS DEVELOPED AFTER EXPOSURE TOA PASTEURIZED DUTCH CONCENTRATE COMPARED TO CLASSIC INHIBITORS IN HEMOPHILIA-A, Thrombosis and haemostasis, 71(6), 1994, pp. 703-706
Risultati: 1-25 | 26-50 | 51-75 | 76-85